Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.77261 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.77883 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.7666 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.73732 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.63891 | 62 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.82091 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.12013 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.8495 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.7593 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.75554 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.86359 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.76009 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.77079 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.77287 | 63 |